Study of the Effectiveness of Mental Contrasting and Implementation Intention in the Management of Apathy in Schizophrenia
NCT ID: NCT04781179
Last Updated: 2022-03-31
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
68 participants
INTERVENTIONAL
2022-02-22
2023-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators aim to propose the CM-II technique to individuals with schizophrenia to improve apathy.
The investigators expected that the CM-II technique will allow an improvement of apathy which will have beneficial effects on other psychological factors (e.g., depressive symptoms). In addition, the implementation of the CM-II will provide help to global management.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessment of the Efficacy of a Fatigue Management Therapy in Schizophrenia
NCT04332601
Apathy in Schizophrenia
NCT01689181
Validation of a Tool for the Dimensional Assessment of Apathy in a Population Suffering From Schizophrenia.
NCT03801551
Cognitive Remediation Program for Hospitalized in the Long Term Patients With Deficit Schizophrenia
NCT03407950
Motive-specific Intervention for Negative Symptoms in Schizophrenia
NCT04793438
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CM-II Technique
CM-II
It is an intervention of 4 two-hour sessions with a psychologist, MC-II technique
Psychoeducation
Psychoeducation
It is an intervention of 4 two-hour sessions with a psychologist, psychoeducation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
CM-II
It is an intervention of 4 two-hour sessions with a psychologist, MC-II technique
Psychoeducation
It is an intervention of 4 two-hour sessions with a psychologist, psychoeducation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Diagnosis of schizophrenia according to DSM 5 criteria.
* Score greater than or equal to -18 on the Lille Apathy Rating Scale
* Ability to understand and speak French.
* Obligation to belong to or be a beneficiary of a social security scheme.
* Signature of the consent. If the participant has a representative, signature by the representative.
Exclusion Criteria
* Current treatment with sismotherapy or repetitive Transcranial Magnetic Stimulation (rTMS).
* Treatment targeted at and/or influencing negative symptoms (CBT, cognitive remediation), or therapeutic trial.
* Participant under safeguard of justice.
* Pregnant or breastfeeding woman.
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Montpellier University Hospital
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
RECHMPL20_0447
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.